Conversely, changes in the expression of CCL2, CCL5, and CCL21 were linked to tumor stages, influencing tumor growth and metastasis by modulating immune cell activity, thereby highlighting their value as therapeutic targets. The gene discussed is CCL2; the disease is neoplasm.